Login to Your Account

Macrocure reverse merger offers running 'Leap' into public markets

By Marie Powers
News Editor

Monday, August 29, 2016

Five-year-old Leap Therapeutics Inc. stands to become a public company as the surviving entity in its merger with the Israeli biopharma, Macrocure Ltd.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription